263 related articles for article (PubMed ID: 12364999)
1. Gene therapy progress and prospects: cystic fibrosis.
Griesenbach U; Ferrari S; Geddes DM; Alton EW
Gene Ther; 2002 Oct; 9(20):1344-50. PubMed ID: 12364999
[TBL] [Abstract][Full Text] [Related]
2. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
3. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
[TBL] [Abstract][Full Text] [Related]
4. Moving forward: cystic fibrosis gene therapy.
Griesenbach U; Alton EW
Hum Mol Genet; 2013 Oct; 22(R1):R52-8. PubMed ID: 23918661
[TBL] [Abstract][Full Text] [Related]
5. Update on gene therapy for cystic fibrosis.
Griesenbach U; Geddes DM; Alton EW
Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
[TBL] [Abstract][Full Text] [Related]
6. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
7. Delivery of genes into the CF airway.
Gill DR; Hyde SC
Thorax; 2014 Oct; 69(10):962-4. PubMed ID: 25015239
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for cystic fibrosis by means of aerosol.
Rochat T; Morris MA
J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
Guggino WB; Cebotaru L
Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for cystic fibrosis: which postman, which box?
Middleton PG; Alton EW
Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.
Teramoto S; Bartlett JS; McCarty D; Xiao X; Samulski RJ; Boucher RC
J Virol; 1998 Nov; 72(11):8904-12. PubMed ID: 9765435
[TBL] [Abstract][Full Text] [Related]
12. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus for cystic fibrosis gene therapy.
Martini SV; Rocco PR; Morales MM
Braz J Med Biol Res; 2011 Nov; 44(11):1097-104. PubMed ID: 21952739
[TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis Gene Therapy in the UK and Elsewhere.
Griesenbach U; Pytel KM; Alton EW
Hum Gene Ther; 2015 May; 26(5):266-75. PubMed ID: 25838137
[TBL] [Abstract][Full Text] [Related]
15. Toward cystic fibrosis gene therapy.
Wagner JA; Gardner P
Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
[TBL] [Abstract][Full Text] [Related]
16. Prospects for gene therapy for cystic fibrosis.
Davies JC; Geddes DM; Alton EW
Mol Med Today; 1998 Jul; 4(7):292-9. PubMed ID: 9743990
[TBL] [Abstract][Full Text] [Related]
17.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
19. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus vectors for gene therapy of cystic fibrosis.
Flotte TR; Carter BJ
Methods Enzymol; 1998; 292():717-32. PubMed ID: 9711594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
